Fujifilm is building a $36 million “smart” manufacturing facility in Tochigi, Japan, to double its endoscope production capability.
EndoGastric Solutions closed a $45 million series I round to fuel commercialization efforts around its TIF 2.0 procedure.
A phase 1 clinical trial found that Landos Biopharma’s Crohn’s disease and ulcerative colitis treatment, BT-11, was well-tolerated with no dose-limiting toxicities or detectable systemic immunosuppression.
More articles on gastroenterology:
Now-defunct Laser Spine Institute under fire over insurance handling — 5 key details
Washington passes surprise-billing law
3 ways ASCs can improve cash flow
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
